Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More
Celerion COVID Entry Requirements
FDA
FDA guidance on conduct of clinical trials
Developing drugs & biological products for treatment
Development and licensure of vaccines to prevent COVID-19
EMA
Implications on methodological aspects of ongoing clinical trials
Guidance for medicine developers and companies on COVID-19
MHRA
Guidance on coronavirus (COVID-19)
Contact
Work with a CRO that generates fast, actionable data you can rely on.
Contact Us
